Total Payments
$1,579
2024 Payments
$103.40
Companies
18
Transactions
36
Medicare Patients
4,820
Medicare Billing
$923,432
Payment Breakdown by Category
Food & Beverage$1,283 (81.2%)
Education$296.45 (18.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,283 | 32 | 81.2% |
| Education | $296.45 | 4 | 18.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $330.25 | 4 | $0 (2023) |
| Medtronic, Inc. | $301.29 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $156.57 | 3 | $0 (2023) |
| PFIZER INC. | $122.82 | 6 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $120.73 | 1 | $0 (2019) |
| Lilly USA, LLC | $112.69 | 3 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $99.99 | 1 | $0 (2019) |
| Incyte Corporation | $89.82 | 3 | $0 (2023) |
| Daiichi Sankyo Inc. | $51.44 | 2 | $0 (2023) |
| Seagen Inc. | $38.31 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $103.40 | 2 | Medtronic, Inc. ($81.27) |
| 2023 | $776.74 | 22 | Medtronic, Inc. ($220.02) |
| 2020 | $18.11 | 1 | PFIZER INC. ($18.11) |
| 2019 | $433.16 | 6 | Novartis Pharmaceuticals Corporation ($120.73) |
| 2018 | $232.07 | 4 | Merck Sharp & Dohme Corporation ($113.00) |
| 2017 | $15.65 | 1 | Merck Sharp & Dohme Corporation ($15.65) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: Hematology | ||||||
| 02/28/2024 | Medtronic, Inc. | OSTEOCOOL RF ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $81.27 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 12/06/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Oncology | ||||||
| 11/30/2023 | PFIZER INC. | BOSULIF (Drug), COMIRNATY, ELREXFIO | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/28/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $29.97 | General |
| Category: Hematology/Oncology | ||||||
| 11/10/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.46 | General |
| 11/02/2023 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $24.35 | General |
| Category: Oncology | ||||||
| 10/25/2023 | PFIZER INC. | IBRANCE (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: ONCOLOGY | ||||||
| 10/20/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $29.89 | General |
| Category: Hematology/Oncology | ||||||
| 10/19/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Oncology | ||||||
| 10/12/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Oncology | ||||||
| 09/07/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $29.96 | General |
| Category: Hematology/Oncology | ||||||
| 08/29/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/13/2023 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $178.86 | General |
| Category: Drug Infusion Systems | ||||||
| 06/20/2023 | PFIZER INC. | IBRANCE (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $41.16 | General |
| Category: Drug Infusion Systems | ||||||
| 06/13/2023 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Oncology | ||||||
| 02/23/2023 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 02/21/2020 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 987 | 2,142 | $540,084 | $151,014 |
| 2022 | 8 | 1,119 | 2,210 | $551,300 | $204,390 |
| 2021 | 8 | 1,392 | 3,166 | $748,973 | $314,236 |
| 2020 | 8 | 1,322 | 3,066 | $766,388 | $253,793 |
Total Patients
4,820
Total Services
10,584
Medicare Billing
$923,432
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 164 | 723 | $231,280 | $72,069 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 198 | $79,240 | $20,958 | 26.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 126 | 142 | $88,173 | $20,545 | 23.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 46 | 46 | $32,243 | $8,285 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 109 | $31,076 | $8,044 | 25.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 45 | 70 | $29,801 | $7,525 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 50 | $28,384 | $7,437 | 26.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 142 | 225 | $5,245 | $1,712 | 32.6% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 28 | 53 | $4,946 | $1,250 | 25.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 20 | 20 | $4,209 | $1,055 | 25.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 82 | 120 | $1,180 | $1,008 | 85.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $2,323 | $610.87 | 26.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 18 | 25 | $1,230 | $317.97 | 25.9% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 11 | 12 | $484.56 | $126.48 | 26.1% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 15 | 20 | $163.62 | $40.35 | 24.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 23 | 232 | $84.08 | $22.76 | 27.1% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 12 | 84 | $21.48 | $6.38 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 421 | 861 | $185,434 | $69,042 | 37.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 126 | 464 | $127,688 | $56,811 | 44.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 216 | $49,378 | $16,724 | 33.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 135 | 205 | $52,211 | $16,222 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 95 | 95 | $39,611 | $14,494 | 36.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 98 | 154 | $39,262 | $12,369 | 31.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 66 | $17,886 | $5,295 | 29.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 40 | $10,991 | $4,767 | 43.4% |
About Dr. Varun Gupta, MD
Dr. Varun Gupta, MD is a Hematology & Oncology healthcare provider based in Palm Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669433306.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Varun Gupta, MD has received a total of $1,579 in payments from pharmaceutical and medical device companies, with $103.40 received in 2024. These payments were reported across 36 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,283).
As a Medicare-enrolled provider, Gupta has provided services to 4,820 Medicare beneficiaries, totaling 10,584 services with total Medicare billing of $923,432. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Palm Springs, FL
- Active Since 03/31/2006
- Last Updated 06/19/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1669433306
Products in Payments
- SYNCHROMEDII (Device) $220.02
- KEYTRUDA (Biological) $140.92
- Padcev (Drug) $124.99
- MEKINIST (Drug) $120.73
- VERZENIO (Drug) $112.69
- JEVTANA (Drug) $99.99
- JAKAFI (Drug) $89.82
- OSTEOCOOL RF ABLATION SYSTEM (Device) $81.27
- IBRANCE (Drug) $57.25
- Enhertu (Drug) $51.44
- INLYTA (Drug) $48.22
- Doptelet (Drug) $28.88
- Lenvima (Drug) $24.35
- DARZALEX (Biological) $22.82
- FOUNDATIONONE (Device) $22.60
- PADCEV (Biological) $22.29
- REBLOZYL (Biological) $22.13
- Xospata (Drug) $20.27
- BOSULIF (Drug) $17.35
- SARCLISA (Biological) $16.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Palm Springs
Dr. Raymond Tsao, M.d, M.D
Hematology & Oncology — Payments: $10,027
Hematology & Oncology $10,027
Dr. Glen Morehead, M.d, M.D
Hematology & Oncology — Payments: $7,736
Hematology & Oncology $7,736
Vijay Narendran, M.d., Mba, M.D., MBA
Hematology & Oncology — Payments: $5,999
Hematology & Oncology $5,999
Dr. Scott Brook, M.d, M.D
Hematology & Oncology — Payments: $3,927
Hematology & Oncology $3,927
Terrence Chew, Md, MD
Hematology & Oncology
Hematology & Oncology